-
Navigating the Global Pricing Policy Landscape and Leveraging AI for Strategic Insights
Sep 22, 2025, 16:24 -
Outcome Assessment in Rare Diseases: Is JCA Breaking the Silos or Perpetuating the Chaos?
Sep 22, 2025, 16:24 -
Leveraging Real-World Data in HTA
Sep 22, 2025, 16:24 -
Plenary Session: Pragmatic Trials—Bridging Research and Real-World Care
Sep 22, 2025, 16:24 -
Plenary Session: Welcome Remarks, Presidential Address, and Awards
Sep 22, 2025, 16:24 -
Diving Into the Intended and Unintended Consequences of how the Societal Perspective is Captured in Cost-Effectiveness Analyses
Sep 22, 2025, 16:24 -
Operationalizing Life-Cycle Health Technology Assessment for Precision Medicine
Sep 22, 2025, 16:24 -
Barriers and Enablers to the Adoption of Innovative Methods for Health Technology Assessment (HTA) Decision Making
Sep 22, 2025, 16:24 -
Beyond Regulatory Approval: Making Patient Experience Central to HTA Decision Making
Sep 22, 2025, 16:24 -
Incorporating Patients' Perspectives in HTA
Sep 22, 2025, 16:24 -
Integrating Capacity-Enhancing Innovations in Healthcare Systems: Are Current Methods Adequate to Demonstrate the Impact on Efficiency and Capacity?
Sep 22, 2025, 16:24 -
Real-World Evidence— From the Clinician’s Perspective
Sep 22, 2025, 16:24 -
Regulatory Update from the European Medicines Agency
Sep 22, 2025, 16:24 -
Embedding Effective Patient Involvement in EU Joint Clinical Assessments
Sep 22, 2025, 16:24 -
Need. Method. Match. Explore the SUSTAIN-HTA Tools
Sep 22, 2025, 16:24 -
Harnessing AI and EHR Data for Rapid Insights on GLP-1s
Sep 22, 2025, 16:24 -
Navigating Complexity in Population Health Decision Making: Evidence, Values, and Real-World Constraints
Sep 22, 2025, 16:24 -
Building HTA Capacity in CEE: Is it Possible to Be Made Within a Common Roadmap—From Pilot Projects to Sustainable Systems
Sep 22, 2025, 16:24 -
Challenges and Methods for JCA in Orphan Indications - Applying Early Learnings
Sep 22, 2025, 16:24 -
HEOR Impact Cases in Affordability and Access
Sep 22, 2025, 16:24